Caitlin C Doan, MD
Gastroenterology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Doan’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A73740 · Current
Licensed to practise in California · since 2001 · expires 2028-09-30 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$3,219
Medicare paid this office $3,219 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 68 · 85 and older 0% · Health risk score 1.81. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
The office billed $21,641, Medicare allowed $4,426 and paid $3,219; for 16 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$221,579
Pharmacies billed $221,579 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
564 generic and fewer than 11 brand-name prescriptions · $221,579 in drug cost · 26 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mesalamine | 91 | $52,321 | $575 |
| Motegrity | 19 | $11,232 | $591 |
| Gavilyte-C | 268 | $6,095 | $23 |
| Lubiprostone | 24 | $2,220 | $93 |
| Cholestyramine | 19 | $810 | $43 |
See all 9 drugs
| Mesalamine | 91 | $52,321 | $575 |
| Motegrity | 19 | $11,232 | $591 |
| Gavilyte-C | 268 | $6,095 | $23 |
| Lubiprostone | 24 | $2,220 | $93 |
| Cholestyramine | 19 | $810 | $43 |
| Pantoprazole | 44 | $576 | $13 |
| Omeprazole | 54 | $518 | $10 |
| Peg-3350 and Electrolytes | 11 | $281 | $26 |
| Famotidine | 13 | $197 | $15 |
Year by year
| 2024 | 641 | 404 | None | None | $221,579 |
| 2023 | 493 | 311 | 0% (0) | None | $86,295 |
| 2022 | 598 | 403 | 0% (0) | 24% | $70,766 |
| 2021 | 424 | 273 | None | 24% | $73,504 |
| 2020 | 361 | 205 | 0% (0) | 24% | $81,050 |
| 2019 | 466 | 313 | 0% (0) | 17% | $100,733 |
| 2018 | 407 | 277 | 0% (0) | None | $106,576 |
| 2017 | 351 | 242 | 0% (0) | 15% | $99,761 |
| 2016 | 367 | 254 | 0% (0) | 20% | $94,625 |
| 2015 | 409 | 277 | 0% (0) | 21% | $102,147 |
| 2014 | 437 | 323 | 0% (0) | 10% | $64,839 |
| 2013 | 485 | 393 | 0% (0) | 7% | $67,598 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Lialda | 35 | $18,567 | $530 |
| Mesalamine | 19 | $14,547 | $766 |
| Gavilyte-C | 185 | $3,887 | $21 |
| Lubiprostone | 11 | $1,686 | $153 |
| Sucralfate | 12 | $533 | $44 |
| Pantoprazole | 33 | $469 | $14 |
| Peg-3350 and Electrolytes | 17 | $447 | $26 |
| Omeprazole | 46 | $421 | $9 |
| Sulfasalazine | 11 | $354 | $32 |
| Clarithromycin | 11 | $235 | $21 |
| Famotidine | 14 | $206 | $15 |
| Metronidazole | 12 | $108 | $9 |
2022: 11 drugs
| Lialda | 37 | $19,145 | $517 |
| Mesalamine | 17 | $10,468 | $616 |
| Gavilyte-C | 236 | $4,090 | $17 |
| Peg-3350 and Electrolytes | 71 | $1,457 | $21 |
| Sucralfate | 16 | $739 | $46 |
| Pantoprazole | 45 | $707 | $16 |
| Cholestyramine | 13 | $538 | $41 |
| Sulfasalazine | 16 | $509 | $32 |
| Omeprazole | 50 | $441 | $9 |
| Famotidine | 17 | $282 | $17 |
| Metronidazole | 11 | $106 | $10 |
2021: 9 drugs
| Lialda | 41 | $26,385 | $644 |
| Peg-3350 and Electrolytes | 79 | $1,607 | $20 |
| Gavilyte-C | 84 | $1,260 | $15 |
| Omeprazole | 50 | $798 | $16 |
| Cholestyramine | 16 | $742 | $46 |
| Peg 3350-Electrolyte | 21 | $567 | $27 |
| Pantoprazole | 23 | $419 | $18 |
| Famotidine | 12 | $131 | $11 |
| Metronidazole | 12 | $104 | $9 |
2020: 9 drugs
| Mesalamine | 29 | $19,496 | $672 |
| Lialda | 27 | $14,394 | $533 |
| Linzess | 13 | $10,315 | $793 |
| Gavilyte-C | 105 | $2,035 | $19 |
| Omeprazole | 39 | $716 | $18 |
| Cholestyramine | 11 | $545 | $50 |
| Peg-3350 and Electrolytes | 15 | $321 | $21 |
| Pantoprazole | 11 | $203 | $18 |
| Famotidine | 15 | $156 | $10 |
2019: 6 drugs
| Lialda | 32 | $34,587 | $1,081 |
| Mesalamine | 11 | $16,180 | $1,471 |
| Linzess | 15 | $10,178 | $679 |
| Gavilyte-C | 215 | $7,672 | $36 |
| Omeprazole | 35 | $657 | $19 |
| Pantoprazole | 24 | $622 | $26 |
2018: 6 drugs
| Lialda | 36 | $57,915 | $1,609 |
| Gavilyte-C | 119 | $4,370 | $37 |
| Peg 3350-Electrolyte | 91 | $3,294 | $36 |
| Azathioprine | 13 | $1,548 | $119 |
| Pantoprazole | 36 | $1,140 | $32 |
| Omeprazole | 44 | $1,041 | $24 |
2017: 5 drugs
| Lialda | 30 | $49,380 | $1,646 |
| Gavilyte-C | 183 | $3,117 | $17 |
| Azathioprine | 15 | $1,491 | $99 |
| Omeprazole | 49 | $1,279 | $26 |
| Pantoprazole | 22 | $683 | $31 |
2016: 5 drugs
| Lialda | 37 | $46,917 | $1,268 |
| Gavilyte-C | 189 | $3,211 | $17 |
| Azathioprine | 12 | $1,372 | $114 |
| Omeprazole | 29 | $1,066 | $37 |
| Pantoprazole | 24 | $751 | $31 |
2015: 6 drugs
| Lialda | 37 | $38,768 | $1,048 |
| Pentasa | 12 | $14,209 | $1,184 |
| Gavilyte-C | 227 | $3,869 | $17 |
| Azathioprine | 18 | $1,393 | $77 |
| Pantoprazole | 23 | $737 | $32 |
| Omeprazole | 14 | $627 | $45 |
2014: 5 drugs
| Lialda | 16 | $16,333 | $1,021 |
| Gavilyte-C | 258 | $4,410 | $17 |
| Azathioprine | 13 | $1,197 | $92 |
| Omeprazole | 22 | $829 | $38 |
| Pantoprazole | 18 | $623 | $35 |
2013: 4 drugs
| Gavilyte-C | 344 | $5,847 | $17 |
| Azathioprine | 11 | $1,128 | $103 |
| Omeprazole | 24 | $973 | $41 |
| Pantoprazole | 13 | $439 | $34 |
Professional record
- NPI
- 1285711135
- Licence
- CA A73740California A73740: Current · expires 2028-09-30
- Trained
- University of California, Geffen School of Medicine, 1999
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A737400
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-31
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.